-
1
-
-
0037115426
-
Cisplatin and etoposide regimen is superior to cyclophosphamide, epirubicin, and vincristine regimen in small cell lung cancer: Results form a randomized phase III trial with 5 years' follow-up
-
Sundstrom S, Bremnes RM, Kaasas S et al. Cisplatin and etoposide regimen is superior to cyclophosphamide, epirubicin, and vincristine regimen in small cell lung cancer: Results form a randomized phase III trial with 5 years' follow-up. J Clin Oncol 2002; 20: 4665-4672.
-
(2002)
J Clin Oncol
, vol.20
, pp. 4665-4672
-
-
Sundstrom, S.1
Bremnes, R.M.2
Kaasas, S.3
-
2
-
-
0034129381
-
Is there a case for cisplafin in the treatment of small-cell lung cancer? A meta-analysis of randomized trials of a cisplatin-containing regimen versus a regimen without this alkylating agent
-
Pujol JL, Carestia L, Daures JP. Is there a case for cisplafin in the treatment of small-cell lung cancer? A meta-analysis of randomized trials of a cisplatin-containing regimen versus a regimen without this alkylating agent. Br J Cancer 2000; 83: 8-15.
-
(2000)
Br J Cancer
, vol.83
, pp. 8-15
-
-
Pujol, J.L.1
Carestia, L.2
Daures, J.P.3
-
3
-
-
0033797356
-
A systematic review of the role of etoposide and cisplatin in the chemotherapy of small cell lung cancer with methodology assessment and meta-analysis. European Lung Cancer Working Party (ELCWP)
-
Mascaux C, Paesmans M, Berghmans T et al. A systematic review of the role of etoposide and cisplatin in the chemotherapy of small cell lung cancer with methodology assessment and meta-analysis. European Lung Cancer Working Party (ELCWP). Lung Cancer 2000; 30: 23-26.
-
(2000)
Lung Cancer
, vol.30
, pp. 23-26
-
-
Mascaux, C.1
Paesmans, M.2
Berghmans, T.3
-
4
-
-
0026482388
-
A meta-analysis of thoracic radiotherapy for small cell lung cancer
-
Pignon JP, Arriagada R, Ihde DC et al. A meta-analysis of thoracic radiotherapy for small cell lung cancer. N Engl J Med 1992; 327: 1618-1624.
-
(1992)
N Engl J Med
, vol.327
, pp. 1618-1624
-
-
Pignon, J.P.1
Arriagada, R.2
Ihde, D.C.3
-
5
-
-
0027399457
-
Importance of timing for thoracic irradiation in the combined modality treatment of limited-stage small cell lung cancer
-
Murray N, Coy P, Patter JL et al. Importance of timing for thoracic irradiation in the combined modality treatment of limited-stage small cell lung cancer. J Clin Oncol 1993; 11: 336-344.
-
(1993)
J Clin Oncol
, vol.11
, pp. 336-344
-
-
Murray, N.1
Coy, P.2
Patter, J.L.3
-
6
-
-
33748445905
-
Early compared with late radiotherapy in combined modality treatment for limited disease small-cell lung cancer: A London Lung Cancer Group multicenter randomized clinical trials and meta-analysis
-
Spiro SG, James LE, Rudd RM et al. Early compared with late radiotherapy in combined modality treatment for limited disease small-cell lung cancer: A London Lung Cancer Group multicenter randomized clinical trials and meta-analysis. J Clin Oncol 2006; 24: 3823-3830.
-
(2006)
J Clin Oncol
, vol.24
, pp. 3823-3830
-
-
Spiro, S.G.1
James, L.E.2
Rudd, R.M.3
-
7
-
-
27244446896
-
Phase III study of adjuvant vaccination with BEC2/Bacille Calmette-Guerin in responding patients with limited-disease small-cell lung cancer (European Organisation for Research and Treatment of Cancer 08971-08971B; Silva Study)
-
Giaccone G, Debruyne C, Felip E et al. Phase III study of adjuvant vaccination with BEC2/Bacille Calmette-Guerin in responding patients with limited-disease small-cell lung cancer (European Organisation for Research and Treatment of Cancer 08971-08971B; Silva Study). J Clin Onool 2005; 23: 6854-6864.
-
(2005)
J Clin Onool
, vol.23
, pp. 6854-6864
-
-
Giaccone, G.1
Debruyne, C.2
Felip, E.3
-
8
-
-
33644991074
-
Time between the first day of chemotherapy and the last day of chest radiation is the most important predictor of survival in limited-disease small-cell lung cancer
-
De Ruysscher O, Pijls-Johannesma M, Bentzen SM et al. Time between the first day of chemotherapy and the last day of chest radiation is the most important predictor of survival in limited-disease small-cell lung cancer. J Clin Oncol 2006; 24: 1057-1063.
-
(2006)
J Clin Oncol
, vol.24
, pp. 1057-1063
-
-
De Ruysscher, O.1
Pijls-Johannesma, M.2
Bentzen, S.M.3
-
9
-
-
0345062339
-
Prophylactic cranial irradiation for patents with small-cell lung cancer in complete remission. Prophylactic Cranial Irradiation Overview Collaborative Group
-
Auperin A, Arriagada R, Pignon JP et al. Prophylactic cranial irradiation for patents with small-cell lung cancer in complete remission. Prophylactic Cranial Irradiation Overview Collaborative Group. N Engl J Med 1999; 341: 476-484.
-
(1999)
N Engl J Med
, vol.341
, pp. 476-484
-
-
Auperin, A.1
Arriagada, R.2
Pignon, J.P.3
-
10
-
-
21344434845
-
Management of small-cell lung cancer
-
Thatcher N, Faivre-Finn C, Lorigan P. Management of small-cell lung cancer. Ann Oncol 2005; (Suppl 2): 235-239.
-
(2005)
Ann Oncol
, Issue.SUPPL. 2
, pp. 235-239
-
-
Thatcher, N.1
Faivre-Finn, C.2
Lorigan, P.3
|